| ORTIN LABORATORIES LIMITED, a Trusted Reliance for Quality established in the year 1986 as a Private Limited Company with a nominal capital of One lakh rupees to offer QUALITY Drugs and Medicines to the suffering mankind. Later, in the year 1994, this Private Limited Company converted as a Public Limited Company with 5,060 shareholders which received good subscription from the Public. These proceeds were utilised for constructing a Factory in a spacious area of 25000 sq feet with all ultra-modern infrastructure as per the WHO GMP Standards to manufacture the complete range of Pharmaceutical Formulations of TABLETS, CAPSULES, SYRUPS, DRY POWDERS & OINTMENTS. Due to our concern for QUALITY, we stand as a leading and predominant Pharmaceutical Manufacturer of Drugs and Medicines of our country with turnover running in crores of rupees.
Ortin has been certified as an ISO 9001: 2000 Company by the internationally recognised Quality Management Certification Body, the National Quality Assurance, UK in pursuance of its focus towards Quality with its Policy to enhance customer satisfaction by providing Quality Pharmaceutical Formulations at optimum cost and maintain profitability through continual improvement of Quality Management Sytems and cGMP.
Ortin, a Public Limited Company, presently trading in the Hyderabad & Madras Stock Exchanges shall shortly commence their trading with the Bombay Stock Exchange.
Ortin is honored as a registered Supplier of Drugs & Medicines with the most reputed Central, State & Quasi-Government Organizations & Institutions of our Country such as the Railways, Health Ministry, Defence, Posts & Telegraph, Electricity Hospitals, Transport Organizations, Research Institutions such as JIPMER, IICT etc. Quality is the Hallmark of Ortin. At every stage of Production from Raw Material to Finished Products, highest standard of Quality is ensured with the help of most modern equipment and experienced personnel. This unflinching perseverance towards quality has helped the company to earn enormous goodwill & trust, both from medical profession and pharmaceutical trade. Being in partnership with the world means respecting its resources without compromise and so at Ortin, continuous process evaluation and monitoring waste recoveries ensure that the focus is maintained. Specialized facilities have helped us to earn a reputation for the expert handling of hazardous materials in the form of reactants and products. Teams from the Ministry of Health regularly inspect our Plant. Every care is taken for treatment of solid wasters, discharged liquids and atmospheric releases.
Ortin is contemplating an entry into the OTC Segment as part of its long term growth strategy. It is channeling its efforts towards building an overseas marketing network in order to enhance exports to third world countries. Ortin proposes to be certified as a WHO GMP Unit and to launch innovative Biotechnology products in Orthopedic and Dental Segments. The success behind us is only the Reliance which we carry for our Quality from the people all over the country. Our motto, right from our inception has been towards Quality and we still maintain them and continue to do so in future.
Recognitions
-Ortin's formulation unit has been certified as a WHO GMP CERTIFIED manufacturing unit and as an ISO 9001: 2008 Company by the internationally recognised Quality Management Certification Body, the BMQR & Accredited by AIAO-BAR, USA in pursuance of its focus towards Quality with its Policy to enhance customer satisfaction by providing Quality Pharmaceutical Formulations at optimum cost and maintain profitability through continual improvement of Quality Management Systems and cGMP.
-Its Drug API Intermediates manufacturing unit has been certified as an ISO 9001: 2008 company by BMQR & Accredited by AIAO-BAR, USA for its quality systems management which shows the quality conscious to deliver best quality products.
2007
-Ortin Laboratories signs 2-year marketing agreement with Canadian Firm
2008
-Ortin Laboratories Recommendation of dividend of 8%
2009
-Ortin Laboratories has recommended 8% dividend
2011
-Ortin Laboratories has recommended Dividend of Rs. 0.50 per equity share.
2012
-Ortin Laboratories has recommended 5%
2013
- Ortin Laboratories Ltd has a Dividend of Rs. 0.25 per share.
2015
-Ortin Laboratories Ltd is listed on BSE.
-Ortin Laboratories changed the Register office within the city limits.
2017
- Company board approved demerger of Undertaking related to API Intermediates Division (Unit - II) of M/s Ortin Laboratories Limited into M/s Vineet Laboratories Limited by way of demerger procedure under sections 230-232 of the Companies Act, 2013 and other relevant provisions of the Companies Act, 2013,
|